CAS Medical Systems, Inc. Sustainability Profile
CAS Medical Systems, Inc., commonly referred to as CAS Medical, is a leading innovator in the medical technology industry, headquartered in the United States. Founded in 1984, the company has established itself as a key player in the development of advanced non-invasive monitoring solutions, particularly in the fields of cerebral and tissue oxygenation. With a strong presence across major operational regions, CAS Medical focuses on providing cutting-edge products that enhance patient care and safety. Their flagship offerings, including the FORE-SIGHT® tissue oximeter, are distinguished by their unique ability to deliver real-time, accurate measurements of oxygen levels in tissues, setting them apart in the competitive landscape. Recognised for their commitment to quality and innovation, CAS Medical has achieved significant milestones, solidifying their market position as a trusted provider of medical monitoring solutions.
DitchCarbon Score
How does CAS Medical Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CAS Medical Systems, Inc.'s score of 67 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CAS Medical Systems, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes Becton, Dickinson and Company, from which it inherits climate commitments and initiatives. Becton, Dickinson and Company has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments and participation in the Carbon Disclosure Project (CDP). These initiatives aim to reduce greenhouse gas emissions across their operations, which may indirectly influence CAS Medical Systems' climate strategy. As a current subsidiary of Becton, Dickinson and Company, CAS Medical Systems aligns with the broader sustainability goals set by its parent company, although specific reduction targets or achievements for CAS Medical Systems have not been disclosed. The company is expected to adhere to the climate commitments cascaded from Becton, Dickinson and Company, which include industry-standard practices for emissions reduction and sustainability. In summary, while CAS Medical Systems, Inc. does not provide specific emissions data or reduction targets, it is positioned within a corporate framework that prioritises climate action and sustainability through its relationship with Becton, Dickinson and Company.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 96,333,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 514,801,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 158,622,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is CAS Medical Systems, Inc.'s Industry?
How Carbon Intensive is CAS Medical Systems, Inc.'s Location?
CAS Medical Systems, Inc.'s Scope 3 Categories Breakdown
CAS Medical Systems, Inc.'s Scope 3 emissions, which decreased by 6% last year and increased significantly since 2008, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 38% of Scope 3 emissions.
Top Scope 3 Categories
CAS Medical Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CAS Medical Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
